Neovascular glaucoma prevention by intravitreal injections of anti-VEGF in patients treated by protontherapy in case of large choroid melanoma

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513746-11-00

Acronym

15-API-01

Enrollment

Registered

2024-10-01

Start date

2017-06-08

Completion date

2025-01-31

Last updated

2024-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient with large choroid melanoma 7 mm thick and/or more than 15 mm of basal diameter treated by proton therapy

Brief summary

Occurrence of neovascular glaucoma after radiation-induced proton therapy. Clinical diagnosis (examination at the slit lamp)

Interventions

DRUGEylea 40 mg/mL solution for injection in pre-filled syringe

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Occurrence of neovascular glaucoma after radiation-induced proton therapy. Clinical diagnosis (examination at the slit lamp)	—

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026